These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1762296)

  • 1. Bone marrow changes following treatment of renal anemia with erythropoietin.
    Horina JH; Schmid CR; Roob JM; Winkler HM; Samitz MA; Hammer HF; Pogglitsch H; Krejs GJ
    Kidney Int; 1991 Nov; 40(5):917-22. PubMed ID: 1762296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
    Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A
    Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
    García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
    Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin.
    Moreno F; Aracil FJ; Pérez R; Valderrábano F
    Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How erythropoietin affects bone marrow of uremic patients.
    Sikole A; Stojanovic A; Polenakovic M; Petrusevska G; Sadikario S; Saso R; Jovanovski M
    Am J Nephrol; 1997; 17(2):128-36. PubMed ID: 9096443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY; Huang JY
    Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.
    Oster W; Herrmann F; Gamm H; Zeile G; Lindemann A; Müller G; Brune T; Kraemer HP; Mertelsmann R
    J Clin Oncol; 1990 Jun; 8(6):956-62. PubMed ID: 2189957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
    Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
    Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.
    Means RT; Olsen NJ; Krantz SB; Dessypris EN; Graber SE; Stone WJ; O'Neil VL; Pincus T
    Arthritis Rheum; 1989 May; 32(5):638-42. PubMed ID: 2719734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.
    Ross RP; McCrea JB; Besarab A
    ASAIO J; 1994; 40(3):M880-5. PubMed ID: 8555638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow findings before and after treatment with recombinant human erythropoietin in chronic hemodialyzed patients.
    Ahn JH; Yoon KS; Lee WI; Suh JT; Lee TW; Ihm CG; Kim MJ
    Clin Nephrol; 1995 Mar; 43(3):189-95. PubMed ID: 7774077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of the bone marrow following treatment with recombinant human erythropoietin in patients with end-stage renal disease.
    Jensen KE; Stenver D; Jensen M; Sørensen PG; Karle H; Thomsen C; Henriksen O; Nielsen B
    Int J Artif Organs; 1990 Aug; 13(8):477-81. PubMed ID: 2228290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
    Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model.
    Messana JM; Chuang CC; Turenne M; Wheeler J; Turner J; Sleeman K; Tedeschi P; Hirth R
    Am J Kidney Dis; 2009 Mar; 53(3):503-12. PubMed ID: 19185402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.